6 Holy Cross Cancer Center in Kielce, Kielce, 25-734, Poland Correspondence: Robert Bucki Department of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2C, Bialystok, 15-222, Poland Tel + 48 85 748 5793 Email [email protected] Background: Even with considerable improvement in treatment of epithelial ovarian cancer achieved in recent years, an increasing chemotherapy resistance and disease 5-year relapse is recorded for a majority part of patients that encourages the search for better therapeutic options
The results of our study are particularly significant, given the unique challenges faced by postmenopausal women with RA
About Leaflet Read all of this leaflet carefully before you start using this medicine because it contains important information for you
For full details on common and serious side effects see the Victoza medication guide or talk to your healthcare provider or pharmacist
0.00 BMI Fill in your height (ft/in) and weight first.